Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomohide Tamura

Showing results (81-90 of 263) with videos related to

Pageof 27
Sort By:
Palliative Medicine Reports|December 20, 2021
Bereaved Family Members' Perceived Care at the End of Life for Patients with Noncancerous Respiratory DiseasesRyosuke Imai, Atsushi Mizuno, Mitsunori Miyashita, et al.
Japanese Journal of Clinical Oncology|July 27, 2007
Effect of platinum combined with irinotecan or paclitaxel against large cell neuroendocrine carcinoma of the lungYutaka Fujiwara, Ikuo Sekine, Koji Tsuta, et al.
Cancer Science|November 9, 2010
Innovator and generic cisplatin formulations: comparison of renal toxicityIkuo Sekine, Kaoru Kubota, Yosuke Tamura, et al.
Japanese Journal of Clinical Oncology|March 12, 2011
Safety of BLP25 liposome vaccine (L-BLP25) in Japanese patients with unresectable stage III NSCLC after primary chemoradiotherapy: preliminary results from a Phase I/II studyFumiyoshi Ohyanagi, Takeshi Horai, Ikuo Sekine, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 24, 2005
Dimerization and the signal transduction pathway of a small in-frame deletion in the epidermal growth factor receptorKazuko Sakai, Tokuzo Arao, Tatsu Shimoyama, et al.
Cancer Science|April 12, 2020
Five-year safety and efficacy data from a phase Ib study of nivolumab and chemotherapy in advanced non-small-cell lung cancerShintaro Kanda, Yuichiro Ohe, Yasushi Goto, et al.
Japanese Journal of Clinical Oncology|August 13, 2003
Phase I and pharmacokinetic study of KRN5500, a spicamycin derivative, for patients with advanced solid tumorsNoboru Yamamoto, Tomohide Tamura, Yoshikazu Kamiya, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Docetaxel consolidation therapy following cisplatin, vinorelbine, and concurrent thoracic radiotherapy in patients with unresectable stage III non-small cell lung cancerIkuo Sekine, Hiroshi Nokihara, Minako Sumi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 25, 2009
Differences in the quality of information on the internet about lung cancer between the United States and JapanYasushi Goto, Ikuo Sekine, Hiroshi Sekiguchi, et al.
International Journal of Radiation Oncology, Biology, Physics|December 25, 2015
Candidates for Intensive Local Treatment in cIIIA-N2 Non-Small Cell Lung Cancer: Deciphering the HeterogeneityHidehito Horinouchi, Yasushi Goto, Shintaro Kanda, et al.
Pageof 27

Showing results (81-90 of 263) with videos related to

Sort By:
Pageof 27
Palliative Medicine Reports|December 20, 2021
Bereaved Family Members' Perceived Care at the End of Life for Patients with Noncancerous Respiratory DiseasesRyosuke Imai, Atsushi Mizuno, Mitsunori Miyashita, et al.
Japanese Journal of Clinical Oncology|July 27, 2007
Effect of platinum combined with irinotecan or paclitaxel against large cell neuroendocrine carcinoma of the lungYutaka Fujiwara, Ikuo Sekine, Koji Tsuta, et al.
Cancer Science|November 9, 2010
Innovator and generic cisplatin formulations: comparison of renal toxicityIkuo Sekine, Kaoru Kubota, Yosuke Tamura, et al.
Japanese Journal of Clinical Oncology|March 12, 2011
Safety of BLP25 liposome vaccine (L-BLP25) in Japanese patients with unresectable stage III NSCLC after primary chemoradiotherapy: preliminary results from a Phase I/II studyFumiyoshi Ohyanagi, Takeshi Horai, Ikuo Sekine, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 24, 2005
Dimerization and the signal transduction pathway of a small in-frame deletion in the epidermal growth factor receptorKazuko Sakai, Tokuzo Arao, Tatsu Shimoyama, et al.
Cancer Science|April 12, 2020
Five-year safety and efficacy data from a phase Ib study of nivolumab and chemotherapy in advanced non-small-cell lung cancerShintaro Kanda, Yuichiro Ohe, Yasushi Goto, et al.
Japanese Journal of Clinical Oncology|August 13, 2003
Phase I and pharmacokinetic study of KRN5500, a spicamycin derivative, for patients with advanced solid tumorsNoboru Yamamoto, Tomohide Tamura, Yoshikazu Kamiya, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Docetaxel consolidation therapy following cisplatin, vinorelbine, and concurrent thoracic radiotherapy in patients with unresectable stage III non-small cell lung cancerIkuo Sekine, Hiroshi Nokihara, Minako Sumi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 25, 2009
Differences in the quality of information on the internet about lung cancer between the United States and JapanYasushi Goto, Ikuo Sekine, Hiroshi Sekiguchi, et al.
International Journal of Radiation Oncology, Biology, Physics|December 25, 2015
Candidates for Intensive Local Treatment in cIIIA-N2 Non-Small Cell Lung Cancer: Deciphering the HeterogeneityHidehito Horinouchi, Yasushi Goto, Shintaro Kanda, et al.
Pageof 27